Tumor Microenvironment in Adrenocortical Carcinoma: Barrier to Immunotherapy Success?

SIMPLE SUMMARY: Adrenocortical carcinoma is a rare but aggressive malignancy with poor outcomes even for patients with early-stage disease. Several immunotherapy clinical trials, many of which are still in progress, have yielded modest results so far. In-depth understanding of the tumor microenviron...

Descripción completa

Detalles Bibliográficos
Autores principales: Georgantzoglou, Natalia, Kokkali, Stefania, Tsourouflis, Gerasimos, Theocharis, Stamatios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069982/
https://www.ncbi.nlm.nih.gov/pubmed/33918733
http://dx.doi.org/10.3390/cancers13081798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069982/
https://www.ncbi.nlm.nih.gov/pubmed/33918733
http://dx.doi.org/10.3390/cancers13081798

Ejemplares similares